Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current concepts and future directions for hemato-oncologic diagnostics.

Critical reviews in oncology/hematology - 1 Jul 2020

Flach Johanna, Shumilov Evgenii, Joncourt Raphael, Porret Naomi, Novak Urban, Pabst Thomas, Bacher Ulrike

Abstract excerpt

At present, hemato-oncologic diagnostics is facing dynamic changes. This applies to the exploration and introduction of novel technologies such as next-generation sequencing or digital droplet PCR for myeloid and lymphatic malignancies in laboratory routine, or liquid biopsy for patients with lymphoid malignancies. Targeted therapies such as FLT3 or IDH1/IDH2 inhibitors for acute myeloid leukemia are entering...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnostic Tests, Routine
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematologic Neoplasms

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Myeloid, Acute

Share to Myelodysplastic Syndromes

Share to Neoplasm, Residual

Share to Precision Medicine

Source

Identifiers

PMID: 32446181
DOI: 10.1016/j.critrevonc.2020.102977

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current concepts and future directions for hemato-oncologic diagnostics.PMID 32446181Read ↗

Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular ToolSemantic proximity Read ↗

Challenges and Opportunities in Liquid Biopsy for Hematologic MalignanciesSemantic proximity Read ↗

The role of next-generation sequencing in hematologic malignanciesSemantic proximity Read ↗

Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review.Semantic proximity Read ↗

Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological MalignanciesSemantic proximity Read ↗

High-throughput sequencing for noninvasive disease detection in hematologic malignanciesSemantic proximity Read ↗

Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.Semantic proximity Read ↗

Clinical applications of cell-free DNA-based liquid biopsy analysisSemantic proximity Read ↗

Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?Semantic proximity Read ↗

Diagnosis and Molecular Pathology of Lymphoblastic Leukemias and Lymphomas in the Era of Genomics and Precision Medicine: Historical Evolution and Current Concepts—Part 2: B-/T-Cell Acute Lymphoblastic LeukemiasSemantic proximity Read ↗

Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignanciesSemantic proximity Read ↗

Liquid biopsies across the cancer care continuum.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.